ATNM USActinium Pharmaceuticals, Inc.United States Composite
Business
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted radiotherapies to deliver cancer-killing radiation to treat patients with high unmet medical needs. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly relapsed or refractory acute myeloid leukemia trial for bone marrow transplant conditioning; and a Phase I study with a CD19- targeted CAR T-cell therapy with memorial sloan kettering cancer center. The company also offers clinical and preclinical development programs that utilize multiple isotopes, including Actinium-225, Iodine-131, and Lutetium-177 directed at multiple targets in oncology and hematology, including CD45, CD33, HER3, and other. It has collaboration with Astellas Pharma, Inc. to develop theranostics for solid tumor indications; EpicentRx, Inc that focuses on a novel CD47 immunotherapy targeted radiotherapy; and AVEO Oncology that focuses on developing a HER3 targeting ARC for solid tumors. The company is based in New York, New York.
8.63
USD
-0.21
(-2.38%)
Actinium Pharmaceuticals, Inc.
ATNM
(United States Composite)
Recent
price
8.63
P/E
ratio
-4.50
div
yld
- -
ROIC.AI
-1.92EPS Dil.
-4.50P/E
236.57MMarket Cap
Legends:
Stock price
-0.05
Beta (1.0 Market)
% total return 05/07
Stock
S&P500
YTD
-38.64
- -
3Y
-25.93
- -
5Y
- -
- -
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.06
0.04
- -
Revenue per ShareRevenue per Share
-0.04
-0.08
-0.06
0.00
0.38
-225.98
-14.21
-27.07
-16.53
-15.06
-11.96
-6.69
-4.40
-1.83
-1.20
-1.37
-1.92
Basic EPS, GAAPBasic EPS, GAAP
-0.04
-0.04
-0.05
0.02
0.02
-140.95
-8.32
-15.90
-14.62
-12.91
-9.70
-5.85
-4.33
-1.80
-1.02
0.34
-1.83
Free Cash Flow per Basic ShareFree Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per ShareDividend per Share
-2.41
-0.61
-0.43
-0.43
-0.40
-77.88
-81.19
-91.27
-76.37
-73.38
-61.10
-48.42
-38.00
-13.17
-11.55
-11.25
-11.97
Book Value per ShareBook Value per Share
-0.43
-0.20
-0.26
-0.25
-0.23
1.61
-1.90
-1.92
14.96
9.68
5.12
2.28
1.03
3.50
3.32
2.59
1.59
Tangible Book Value per ShareTangible Book Value per Share